Correct me if I'm wrong, but a 5% and growing position like the one Aspire has sounds pretty heavy to me. Wouldn't their position be concidered an institutional holding?
agreed, NON-Genotoxic and now proven tumor regression...did you hear that Biotech Investment groups....They read posts here.....How would you like to be holding this before Leo says SOLD